Quest Diagnostics
DGX
#1067
Rank
NZ$30.52 B
Marketcap
$273.47
Share price
2.30%
Change (1 day)
20.90%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$27.43 Billion

According to Quest Diagnostics 's latest financial reports the company's total assets are NZ$27.43 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Quest Diagnostics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$22.17 B9.66%
2022-12-31NZ$20.21 B1.46%
2021-12-31NZ$19.92 B2.51%
2020-12-31NZ$19.43 B1.94%
2019-12-31NZ$19.06 B16.25%
2018-12-31NZ$16.40 B10.92%
2017-12-31NZ$14.78 B1.43%
2016-12-31NZ$14.58 B0.17%
2015-12-31NZ$14.55 B15.7%
2014-12-31NZ$12.58 B15.54%
2013-12-31NZ$10.88 B-3.52%
2012-12-31NZ$11.28 B-5.43%
2011-12-31NZ$11.93 B7.96%
2010-12-31NZ$11.05 B-6.25%
2009-12-31NZ$11.79 B-18.58%
2008-12-31NZ$14.48 B29.5%
2007-12-31NZ$11.18 B39.15%
2006-12-31NZ$8.03 B3.52%
2005-12-31NZ$7.76 B31.77%
2004-12-31NZ$5.89 B-10.97%
2003-12-31NZ$6.61 B4.18%
2002-12-31NZ$6.35 B-10%
2001-12-31NZ$7.05 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$31.72 B 15.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.23 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.79 B-89.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.14 B-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$9.51 B-65.30%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands